Advances in pharmacotherapy of juvenile idiopathic arthritis.

Journal: Expert opinion on pharmacotherapy
Published Date: May 3, 2025

Abstract

INTRODUCTION: Juvenile Idiopathic Arthritis (JIA) is the most common chronic rheumatic disease in childhood. More therapeutic options are available for the treatment of JIA with more children achieving minimal active disease or inactive disease status.

Authors

  • Stephanie K A Wong
    Section of Rheumatology, Department of Pediatrics, British Columbia Children's Hospital, University of British Columbia, Vancouver, BC, Canada.
  • Simone Appenzeller
    Department of Orthopedics, Rheumatology and Traumatology, School of Medical Science, University of Campinas (UNICAMP), Sao Paulo, Brazil.
  • Marinka Twilt
    Section of Rheumatology, Department of Pediatrics, Alberta Children's Hospital, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals